RxDoctor Payments Data

James Bigham

Physician Assistant · Mesa, AZNPI 1962837245

Payments from drug & device makers

$11,621in general payments, 2019–2025

Across 729 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Collegium Pharmaceutical, Inc.$2K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$985
  • Pfizer$464
  • Scilex Pharmaceuticals Inc.$388
  • plus $5K from 40 others

What the payments were for

  • Consulting fees$8007%
  • Food & beverage$10,70392%
  • Education$1181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,621 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$99,998
Medicare patients
242
Services billed
3,773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl65$57,468
NucyntaTapentadol Hcl35$40,640
OxycontinOxycodone Hcl33$37,659
Xtampza ErOxycodone Myristate65$34,712
Buprenorphine160$29,356
MovantikNaloxegol Oxalate62$26,100
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen670$19,175
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen523$17,815
Nucynta ErTapentadol Hcl15$17,570
Nurtec OdtRimegepant Sulfate12$16,145
Tramadol Hcl ErTramadol Hcl144$8,685
Gabapentin385$7,287
Lidocaine55$7,040
Oxycodone Hcl389$6,619
Morphine Sulfate ErMorphine Sulfate207$5,375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Xtampza Er, Nucynta Er$1,638$150,390180 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl$172$34,720353 claims
Redhill Biopharma Inc.Movantik$29$26,10062 claims
PfizerNurtec Odt$464$16,14512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →